| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |